Production (Stage)
Whitehawk Therapeutics, Inc.
WHWK
$1.91
-$0.06-3.05%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 499.23% | -12.32% | 23.04% | 18.85% | -20.14% |
| Total Depreciation and Amortization | 14.00% | 6.82% | 6.82% | 13.95% | 31.58% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -2,664.97% | -36.20% | -9.05% | 11.27% | 94.87% |
| Change in Net Operating Assets | 115.42% | -62.90% | -419.53% | 347.14% | 39.35% |
| Cash from Operations | 39.63% | -56.09% | -31.26% | 45.36% | 7.78% |
| Capital Expenditure | 25.44% | 77.21% | 82.88% | 21.48% | 46.02% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 30.10% | 198.30% | -61.69% | -105.91% | -36.18% |
| Cash from Investing | 994.25% | 259.91% | -59.86% | -107.06% | -35.36% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -54.39% | -100.00% | -74.03% | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -48,120.00% | 102.94% | 100.00% | 85.71% | -- |
| Cash from Financing | 952,110.00% | -33.75% | 100.00% | -72.20% | -225.00% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2,283.08% | 68.44% | -1,753.98% | -137.05% | -83.15% |